AvePoint AVPT 深 滬
等待開盤 11-07 09:30:00 美东时间
16.55
+0.130
+0.79%
華盛通- 最 高16.89
- 今 開16.89
- 成交量 381.19万股
- 最 低 16.00
- 昨 收 16.42
- 總市值 35.01亿
- 52周最高 17.52
- 市盈率 靜 109.03
- 換手率 1.80%
- 52周最低 8.835
- 委 比 76.71%
- 總股本 2.12亿
- 歷史最高 20.245
- 量 比 0.45
- 振 幅 5.42%
- 歷史最低 3.40
- 每 手 1
- 風險率 1.83%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多财报速睇 | AvePoint 2026财年Q3营收1.31亿美元，同比增长19.5%；归母净利润0.18亿美元，同比增长37.8%
华盛资讯11月6日讯，AvePoint公布2026财年Q3业绩，公司Q3营收1.31亿美元，同比增长19.5%，归母净利润0.18亿美元，同比增长37.8%。
11-06 11:16
财报速睇 | AvePoint 2026财年Q3营收1.31亿美元，同比增长19.5%；归母净利润0.18亿美元，同比增长37.8%
华盛资讯11月6日讯，AvePoint公布2026财年Q3业绩，公司Q3营收1.31亿美元，同比增长19.5%，归母净利润0.18亿美元，同比增长37.8%。
11-06 08:46
AvePoint Raises FY2026 Sales Guidance from $508.500M-$512.500M to $511.300M-$513.300M vs $510.597M Est
AvePoint (NASDAQ:AVPT) raises FY2026 sales outlook from $508.500 million-$512.500 million to $511.300 million-$513.300 million vs $510.597 million estimate.
11-06 05:14
美股大行评级 | 苹果、雅诗兰黛、莱迪思半导体均获大行上调目标价
今日重点评级关注：Rosenblatt：维持SiTime"买入"评级，目标价从750美元升至900美元；花旗：维持Madrigal Pharmaceuticals"买入"评级，目标价从725美元升至760美元
11-04 18:17
AvePoint Appoints Ali Rohani as Chief Strategy and Customer Officer
AvePoint appoints Ali Rohani as Chief Strategy and Customer Officer to deepen customer value and accelerate growth in AI Trust. Rohani, with over 25 years of experience in enterprise software, will lead AvePoint’s strategy to connect customer needs with market insights. AvePoint recently launched the AvePoint Trust Platform and was included in Gartner’s Magic Quadrant for AI Agent Management Platforms, positioning the company as a leader in the e...
11-04 14:00
TD Cowen Maintains Buy on AvePoint, Raises Price Target to $18
TD Cowen analyst Derrick Wood maintains AvePoint (NASDAQ:AVPT) with a Buy and raises the price target from $15 to $18.
11-03 23:31
AvePoint Set to Join S&P SmallCap 600
NEW YORK, Oct. 27, 2026 /PRNewswire/ -- AvePoint Inc. (NASD: AVPT) will replace LXP Industrial Trust (NYSE: LXP) in the S&P SmallCap 600 effective prior to the opening of trading on Monday, ...
10-28 05:34
AvePoint, the AI Trust Company, Announces the AvePoint Trust Platform to Govern, Secure, and Optimize AI
AvePoint introduced its Trust Platform, empowering organizations to govern, secure, and optimize AI across all agents, models, and vendors. The platform includes new AI Governance and Security capabilities for unified management, visibility, and compliance, as well as cost optimization tools to maximize AI investment returns. It supports Anthropic Claude, Windows, and server-hosted agents, offering backup, recovery, and lifecycle governance. AveP...
10-27 13:00
美股大行评级 | 潜在涨幅101.01%！Stifel上调ORIC Pharmaceuticals目标价至18美元，维持"买入"评级
今日重点评级关注：Stifel：维持ORIC Pharmaceuticals"买入"评级，目标价从14美元升至18美元；花旗：维持Liberty Energy"买入"评级，目标价从27.5美元升至28美元
10-27 12:30
Jefferies Maintains Buy on AvePoint, Raises Price Target to $20
Jefferies analyst Joseph Gallo maintains AvePoint (NASDAQ:AVPT) with a Buy and raises the price target from $16 to $20.
10-26 20:38
